The research on cannabis and insomnia is better in the short term than most people expect, and more complicated in the long term than most product pages will tell you. Cannabis does appear to reduce sleep onset time and improve self-reported sleep quality for many people. It also suppresses REM sleep, builds tolerance with consistent use, and can temporarily worsen insomnia during the first week after stopping. None of that makes it a bad sleep tool. It makes it a tool worth understanding before you use it.
🧪 Lab Tested | 👩💼 Woman-Owned | 🏆 Est. 2017
This article is educational and does not constitute medical advice. Insomnia can have multiple underlying causes, some of which require medical evaluation. If you have chronic insomnia, speak with a healthcare provider before beginning any new supplement regimen. Cannabis is not an FDA-approved treatment for insomnia.
The Research Landscape
A 2017 review in Current Psychiatry Reports covering cannabis and sleep concluded that the short-term evidence was reasonably favorable: THC appeared to decrease sleep onset latency (how long it takes to fall asleep) and reduce nighttime waking in some populations. The same review identified a significant gap: most studies were small, short-duration, and often industry-funded. Large-scale randomized controlled trials for cannabis and insomnia simply don’t exist at the scale that exists for prescription sleep medications.
Babson, K.A., Sottile, J., & Morabito, D. (2017). “Cannabis, Cannabinoids, and Sleep: a Review of the Literature.” Current Psychiatry Reports, 19(4), 23. PubMed: 28349316.
The research quality issue matters because insomnia is heterogeneous. Someone who can’t fall asleep because of anxiety has a different underlying problem than someone who wakes at 3 AM due to pain, or someone whose sleep architecture is disrupted by aging. Cannabis may address some of these mechanisms more effectively than others, and the research often doesn’t distinguish between them.
Reasonably supported
Sleep onset
THC-containing products appear to reduce how long it takes to fall asleep, across multiple small trials. Effect is consistent enough to be considered credible, though effect size varies by dose and population.
Reasonably supported
Subjective sleep quality
Self-reported sleep quality improvements are consistent across observational studies. Users consistently rate their sleep as better. Objective polysomnography data is more mixed.
Real concern
REM sleep suppression
THC reduces time spent in REM sleep, which is the dream-active phase associated with memory consolidation and emotional processing. This is well-established across multiple study types.
Limited evidence
Long-term efficacy
Most studies run 2 to 8 weeks. Tolerance development means initial sleep benefits may diminish. Long-term data on chronic insomnia specifically is thin.
THC and Sleep: Short-Term vs. Long-Term
THC is the cannabinoid with the most direct evidence for sleep effects. It binds to CB1 receptors in the brain, including areas involved in regulating sleep-wake cycles. The sedative quality many users experience is real: THC shortens the time from wakefulness to sleep, and at moderate doses, reduces the frequency of nighttime waking.
The short-term picture is genuinely useful for many people with insomnia. Pain-related insomnia in particular has a reasonable evidence base: when physical discomfort is what’s keeping someone awake, THC’s analgesic and sedative properties address both simultaneously. “I have chronic back pain which causes problems sleeping. One of these gummies taken at bedtime has helped greatly at getting a full night sleep,” Duane F. “It truly helps me with insomnia and my severe anxiety!” Erica S.
The long-term picture is more complicated. Daily THC use over weeks produces measurable tolerance to its sleep effects; the same dose produces less sedation over time. Some chronic users report needing progressively higher doses to achieve the same sleep onset effect. The other concern is sleep architecture: REM sleep suppression is a real effect that accumulates with consistent use.
CBD and Insomnia
CBD’s relationship to sleep is more indirect than THC’s. CBD doesn’t produce sedation through direct CB1 receptor activation; its sleep-relevant effects appear to come primarily from anxiety reduction. If anxiety or a racing mind is the primary driver of your insomnia, CBD addresses that mechanism. If pure physiological sleep difficulty is the issue, CBD alone has weaker evidence.
A small but meaningful body of research suggests CBD may improve sleep in people whose insomnia is anxiety-driven. One frequently cited 2019 case series in The Permanente Journal found that 79.2% of patients with anxiety-related sleep complaints reported improvement in anxiety scores over the study period, with sleep scores improving in 66.7% of patients in the first month.
Shannon, S., Lewis, N., Lee, H., & Hughes, S. (2019). “Cannabidiol in Anxiety and Sleep: A Large Case Series.” The Permanente Journal, 23, 18-041. PubMed: 30624194.
The dose question with CBD is meaningful. Several studies suggest lower doses of CBD may actually promote wakefulness rather than sleep, while higher doses produce sedation. This dose-dependent pattern is not a reason to avoid CBD. It is a reason to understand that “more CBD” and “better sleep” aren’t automatically the same thing. The CBD + CBN Sleep Gummies (with B6 and L-Tryptophan) address this by pairing CBD with compounds that specifically support the sleep-initiation pathway rather than relying on CBD alone.
CBN: What the Evidence Actually Shows
CBN is the most aggressively marketed cannabinoid for sleep, and the one with the weakest standalone evidence base. A 2021 literature review in Cannabis and Cannabinoid Research examined the specific evidence for CBN as a sleep aid and found it unconvincing when isolated from other cannabinoids. Most studies that attributed sedation to CBN were conducted with aged cannabis containing multiple compounds, not CBN alone.
Corroon, J. (2021). “Cannabinol and Sleep: Separating Fact from Fiction.” Cannabis and Cannabinoid Research, 6(5), 366-371. PubMed: 34468204.
What CBN does have evidence for is synergistic effects in combination with THC and CBD. When paired with THC, CBN appears to deepen and extend sedation beyond what THC produces alone. When paired with CBD, it contributes a complementary sedative pathway that broadens the effect without adding intoxication. CBN gummies and tinctures formulated as combination products (CBN + THC, or CBN + CBD) have a more defensible evidence base than CBN-only products. “These gummies are the holy grail of peaceful sleep. I don’t have trouble falling asleep but I wake up all throughout the night. Until I got these! Finally a good night’s sleep,” Cody H.
The REM Sleep Question
REM sleep is where most dreaming happens. It’s also the phase associated with emotional memory processing, creativity, and certain kinds of learning consolidation. The evidence that THC suppresses REM sleep is among the most consistent findings in cannabis sleep research, replicated across multiple study designs over decades.
What this means in practice: people who use THC regularly for sleep often report dreaming less, or not remembering dreams. That might sound like a minor side effect, but REM sleep serves real cognitive and emotional functions. Whether clinically meaningful disruption occurs at typical consumer doses and durations is still genuinely debated in the research.
Two additional observations are useful here. First, CBD does not appear to suppress REM sleep in the way THC does; it may actually support REM in some study populations. Second, when people stop using THC after a period of regular use, REM sleep rebounds: vivid and sometimes intense dreams return as the brain restores what was suppressed. This REM rebound is temporary and settles over a week or two, but it can be disorienting.
For people using cannabis for sleep who want to minimize REM disruption, CBD-dominant or CBN + CBD formulations are a more conservative choice than THC-containing ones, particularly for nightly use.
Tolerance and Long-Term Use
Cannabis tolerance develops with consistent use, more rapidly with THC than with CBD. The sleep-onset benefit that feels dramatic in week one tends to flatten out by weeks three or four without dose increases. This doesn’t mean cannabis stops working entirely; subjective sleep quality often remains improved even as the acute sedative effect moderates. But it does mean nightly full-dose use is not an indefinitely sustainable strategy at a fixed dose.
Three practical approaches slow tolerance development. Cycling (taking one or two nights off per week) prevents the continuous receptor saturation that drives rapid tolerance. Rotating formulations (alternating between THC-containing and CBD-only products across nights or weeks) means tolerance to one formulation doesn’t eliminate the benefit of the other. Dose restraint matters too: using the minimum dose that produces the desired sleep effect preserves headroom for future adjustments without constantly escalating.
The withdrawal consideration is real but manageable. After a period of nightly THC use, stopping abruptly can produce a few nights of worse-than-baseline sleep, vivid dreams (REM rebound), and restlessness. This is not dangerous, but it can feel alarming if unexpected. Tapering down rather than stopping cold, and expecting a one-to-two-week adjustment window, makes the transition smoother. “I have been using CBN Tincture for sleep for nearly a year and it is wonderful to help me fall asleep,” Nancy B.
Who Benefits Most
Research-supported use cases and cautions
More likely to benefit
- Sleep disrupted primarily by anxiety or a racing mind (CBD pathway most relevant)
- Sleep disrupted by chronic pain (THC’s analgesic + sedative combination addresses both)
- Trouble with sleep onset specifically (fastest effect is on time to fall asleep)
- Intermittent or situational insomnia rather than chronic nightly disruption
- People who have failed over-the-counter sleep aids and want a non-pharmaceutical option
Use with more caution
- Anyone who cannot afford positive drug test results (THC-containing products will produce a positive)
- People with sleep apnea: some evidence suggests cannabis may affect respiratory drive during sleep
- People with a history of cannabis use disorder: the sleep-disruption withdrawal pattern can reinforce problematic use cycles
- Those who rely heavily on dream recall or REM-dependent cognitive tasks the following day
Insomnia driven by underlying conditions (sleep apnea, restless leg syndrome, circadian rhythm disorders) is less likely to be addressed by cannabinoids, because the root cause isn’t something CBD or THC targets directly. For these, a sleep medicine evaluation is the right starting point before adding any supplement.
TribeTokes Sleep Products
THC/CBN Sleep Gummies
Delta-9 THC + CBN + L-Tryptophan. Vegan, pectin-based, 20-count. The strongest sleep formulation in the lineup; addresses both sleep onset and sleep maintenance for many users. 4.60/5 from 42 verified reviews. Contains Delta-9 THC; will produce a positive result on a standard drug test. Browse at tribetokes.com/thc-gummies-for-sleep.
CBD + CBN Sleep Gummies
CBD + CBN + B6 + L-Tryptophan. THC-free. Non-psychoactive option for anxiety-driven insomnia or users subject to drug testing. Particularly useful for people whose sleep disruption is anxiety-mediated. Browse at tribetokes.com/cbd-sleep-gummies.
CBN Tincture for Sleep
Full-spectrum, CBD-boosted, 1,800mg per 30mL, MCT oil base. Sublingual delivery produces onset in 15 to 45 minutes. Flexible dosing via dropper. 4.86/5 from 14 verified reviews. Full-spectrum formulation carries low but real drug test risk from trace Delta-9 THC. Browse at tribetokes.com/tinctures-for-sleep.
CBN Live Resin Gummies
1:1 CBD:CBN, 600mg, CBD-boosted, live resin extraction. Full-spectrum. 4.52/5 from 27 verified reviews. Browse at tribetokes.com/cbn-sleep-gummies.
For guidance on which combination works for your sleep problem, see CBN, THC & CBD combinations for sleep. For timing guidance, see when to take cannabis for sleep.
Frequently Asked Questions
Research suggests cannabis, particularly THC-containing products, reduces the time it takes to fall asleep and improves self-reported sleep quality in the short term. A 2017 review in Current Psychiatry Reports found consistent evidence for sleep onset benefits across multiple small trials. The effect on staying asleep and overall sleep architecture is more variable, and the evidence base is substantially weaker than what exists for prescription sleep medications. Cannabis is not an FDA-approved insomnia treatment, and the quality of available research is limited by small sample sizes and short study durations.
They address different mechanisms and suit different insomnia types. THC has more direct sedative evidence: it reduces sleep onset time and nighttime waking through CB1 receptor activation. CBD’s sleep effects are more indirect, primarily via anxiety reduction; it works best for insomnia driven by a racing mind or anxious arousal rather than physiological sleep difficulty. For most people with mixed presentations, combination products (THC + CBN, or CBD + CBN with L-Tryptophan) outperform either cannabinoid used alone.
Yes. THC suppresses REM sleep, which is the dream-active phase associated with emotional memory processing and certain kinds of learning consolidation. This is one of the most consistent findings in cannabis sleep research. Regular THC users often report dreaming less or not recalling dreams. CBD does not appear to suppress REM sleep to the same degree. When someone stops using THC after a period of regular use, REM sleep rebounds: vivid dreams return temporarily as the brain restores what was suppressed. This rebound typically settles over one to two weeks.
Tolerance develops with consistent THC use, typically becoming noticeable over two to four weeks of nightly use at the same dose. The acute sedative effect that feels dramatic early on tends to flatten without dose adjustments. Subjective sleep quality often remains improved even as the sedative threshold rises. Three strategies slow tolerance development: cycling (one to two nights off per week), rotating between THC-containing and CBD-dominant formulations, and using the minimum dose that produces the target effect rather than escalating preemptively.
After a period of regular THC use for sleep, stopping abruptly typically produces one to two weeks of disrupted sleep: worse sleep onset, vivid or intense dreams (REM rebound), and sometimes restlessness. This is the most commonly reported cannabis withdrawal effect and is temporary. It does not indicate harm; it reflects the brain restoring REM sleep that was suppressed. Tapering dose gradually rather than stopping cold reduces the intensity of this transition. CBD-dominant products don’t appear to produce the same withdrawal sleep disruption.
CBN in isolation has limited evidence as a standalone sleep aid. A 2021 review in Cannabis and Cannabinoid Research concluded that most studies attributing sedation to CBN had actually used aged cannabis containing multiple cannabinoids, not isolated CBN. In combination with THC or CBD, CBN appears to contribute meaningfully to sleep depth and duration, which is why combination products consistently outperform CBN-only options in user reports. CBN is better understood as a synergistic compound rather than a primary sleep agent.
Nightly use is common and not acutely dangerous for most healthy adults. The real considerations are tolerance development (which reduces efficacy over time at a fixed dose), REM sleep suppression (which accumulates with consistent THC use), and withdrawal sleep disruption when stopping. For people who want to use cannabis for sleep long-term, building in regular breaks, using the lowest effective dose, and preferring CBD-dominant or CBN-only formulations on alternating nights all reduce these risks meaningfully. Consult a healthcare provider if you have any conditions affecting sleep, are taking medications, or have a history of cannabis dependence.
The evidence is strongest for insomnia characterized by trouble falling asleep, and for insomnia where pain or anxiety is the primary driver. THC’s analgesic properties make it particularly useful when physical discomfort disrupts sleep, since it addresses both the pain and the sleep difficulty simultaneously. CBD has the strongest supporting logic for anxiety-driven insomnia. Insomnia caused by structural sleep disorders like sleep apnea, restless leg syndrome, or circadian rhythm disruption is less likely to be addressed by cannabinoids, since the underlying mechanism is different. A sleep medicine evaluation is appropriate before adding any supplement for these conditions.
Third-Party Tested Sleep Products
THC + CBN combinations, CBD + CBN THC-free options, and tinctures for precise dosing. COA on every batch.